- Report
- October 2024
- 114 Pages
North America
From €3095EUR$3,450USD£2,722GBP
- Report
- May 2024
- 210 Pages
Global
From €3992EUR$4,450USD£3,511GBP
- Report
- May 2024
- 124 Pages
Global
From €3544EUR$3,950USD£3,117GBP
- Report
- April 2023
- 69 Pages
India
From €4261EUR$4,750USD£3,748GBP
- Report
- April 2023
- 108 Pages
Europe
From €3095EUR$3,450USD£2,722GBP
- Report
- April 2023
- 178 Pages
Global
From €4441EUR$4,950USD£3,906GBP
- Report
- April 2024
- 140 Pages
Global
From €4458EUR$4,969USD£3,921GBP
- Report
- July 2023
- 120 Pages
Saudi Arabia
From €2502EUR$2,789USD£2,201GBP
- Report
- July 2024
- 154 Pages
Global
From €3241EUR$3,613USD£2,850GBP
€3813EUR$4,250USD£3,353GBP
- Report
- November 2023
- 150 Pages
Global
From €3454EUR$3,850USD£3,038GBP
€4351EUR$4,850USD£3,827GBP
- Report
- November 2024
- 150 Pages
Global
From €3454EUR$3,850USD£3,038GBP
€4351EUR$4,850USD£3,827GBP
- Report
- November 2022
- 87 Pages
Asia Pacific
From €1346EUR$1,500USD£1,183GBP
- Report
- July 2023
- 252 Pages
Global
From €3230EUR$3,600USD£2,840GBP
The Ocular Disease market within the Optical industry is a specialized sector that focuses on the diagnosis and treatment of eye diseases. It includes a range of products and services, such as ophthalmic drugs, diagnostic equipment, and surgical instruments. Ocular Disease treatments are often tailored to the individual patient, and may include medications, laser treatments, and surgery.
The Ocular Disease market is highly competitive, with a variety of companies offering products and services. Some of the major players in the market include Johnson & Johnson, Novartis, Allergan, Bausch & Lomb, and Abbott Laboratories. Other companies in the market include Alcon, Carl Zeiss, Essilor, Hoya, and Santen. Show Less Read more
